The Pennant Group Inc. is turning to artificial intelligence as it expands its hospice and home‑health operations, a strategy outlined by CEO Brent Guerisoli during the recent earnings call.
AI pilots aim to cut paperwork and boost capacity
Guerisoli said the firm is testing AI tools that shorten clinical documentation and automate back‑office tasks. “Specifically related to using AI and the tools available, they are going to be essential to delivering more effective, more efficient care,” he told analysts. The firm hopes the technology will free clinicians to see more patients while trimming indirect costs.
Investments in the technology platform have been sizable, according to the CEO. “We’ve spent a large amount of money and investment in driving and improving performance from a technology standpoint. There’s a major opportunity … we believe it’s part of our future.” He added that better quality outcomes and stronger financial results are expected as the AI rollout matures.
In the second quarter, Pennant reported revenue of $298 million, a 35.8 % jump from the same period a year earlier. Adjusted EBITDA rose to $24.3 million, up $7.9 million versus the prior year. The hospice and home‑health segment contributed roughly $237.8 million, reflecting a 43.2 % increase.
Growth fueled by recent acquisition and community focus
The expansion was accelerated by a $146.5 million purchase of assets formerly owned by Amedisys and UnitedHealth Group. The deal added 54 locations in Alabama, Georgia and Tennessee to Pennant’s network, which already includes 175 hospice and home‑health providers and 69 senior‑living communities across 13 states.
Chief operating officer John Gochnour highlighted the locally driven approach that underpins the firm’s growth. He said understanding community needs and nurturing referral relationships are essential for meeting rising demand.
Related: How Long Does Delta-8 Oil Take To Kick In?
Regulators have tightened oversight of hospice providers, introducing a new 2027 payment rule that creates a service and spending variation index to flag potential fraud. Gochnour acknowledged that compliance costs will rise but argued the measures protect legitimate operators.
From a broader perspective, the push toward AI could serve as a buffer against the administrative burdens imposed by tighter regulations. If the technology successfully reduces paperwork, Pennant may be able to allocate more resources toward patient care rather than compliance staff, a shift that could enhance its reputation in a scrutinized market.
Financial snapshot and outlook
Senior‑living revenues reached $60.2 million, up 12.6 % from the previous year. The hospice average daily census stood at 5,477 patients in the quarter, indicating solid demand for end‑of‑life services.
Despite the regulatory headwinds, the firm’s “rigorous investment and innovation” has helped it manage a challenging reimbursement environment, according to Gochnour. The company plans to continue integrating its newly acquired sites while expanding AI usage across its operations.
Analysts will be watching how quickly the AI pilots translate into measurable cost savings and whether the technology can sustain the growth trajectory that has already delivered double‑digit revenue gains.
They remain optimistic.
